Clinical Trial Update: Absorption, Distribution, Metabolism And Excretion Study For GSK221149A [Phase 1]

View source ↗

Summary

Phase 1 PK study evaluating absorption, distribution, metabolism, and excretion of GSK221149A in pregnancy-related obstetric labor conditions; the trial is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Preterm Labor

Drugs mentioned

• GSK221149A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Obstetric Labour, Premature, Premature Labor | Phase 1 | Status: COMPLETED